Johnson & Johnson (JNJ) has 20 known insider and institutional holders on record. The largest holder is McEvoy Ashley with 52,038 shares. Other notable holders include Washington A. Eugene and WILLIAMS RONALD A.
Over the last 12 months, insiders have made 75 transactions in JNJ stock — 32 buys (valued at $257.69K) and 6 sells (valued at $20.51M). Insider buying has outpaced selling during this period, which may signal confidence in the company's prospects.
JNJ Insider Ownership
Top Holder
McEvoy Ashley
52,038 shares
Buys (12 mo)
32
$257.69K value
Sells (12 mo)
6
$20.51M value
12-Month Transaction Activity
Top Insider Holders
| # |
Name |
Role |
Shares Owned |
Last Filed |
Relative Size |
| 1 |
Mcevoy Ashley |
EVP, Ww Chair, Medtech |
52,038 |
2023-08-25 |
|
| 2 |
Washington A. Eugene |
Director |
28,569 |
2023-03-09 |
|
| 3 |
Williams Ronald A |
Director |
25,673 |
2022-02-17 |
|
| 4 |
Schmid Timothy |
EVP, Ww Chair, Medtech |
25,447 |
2026-02-23 |
|
| 5 |
Prince Charles |
Director |
24,824 |
2022-02-17 |
|
| 6 |
Mulcahy Anne M |
Director |
21,471 |
2024-04-29 |
|
| 7 |
Mcclellan Mark B. |
Director |
19,755 |
2025-04-28 |
|
| 8 |
Davis Ian |
Director |
17,706 |
2022-02-17 |
|
| 9 |
Davis D Scott |
Director |
15,604 |
2024-10-15 |
|
| 10 |
Beckerle Mary C |
Director |
15,395 |
2025-04-28 |
|
| 11 |
Hewson Marillyn A |
Director |
14,306 |
2026-03-12 |
|
| 12 |
Gorsky Alex |
Director |
11,047 |
2022-02-17 |
|
| 13 |
Weinberger Mark A |
Director |
10,737 |
2025-04-28 |
|
| 14 |
Doudna Jennifer A |
Director |
9,656 |
2025-04-28 |
|
| 15 |
Joly Hubert |
Director |
7,987 |
2025-04-28 |
|
| 16 |
West Nadja |
Director |
6,573 |
2025-04-28 |
|
| 17 |
Woods Eugene A. |
Director |
5,240 |
2026-03-12 |
|
| 18 |
Johnson Paula A |
Director |
4,266 |
2025-04-28 |
|
| 19 |
Mammen Mathai |
EVP, Pharm, R&d |
3,922 |
2022-02-17 |
|
| 20 |
Adamczyk Darius |
Director |
3,713 |
2024-04-29 |
|
Recent Transactions (last 12 months)
| Date |
Name |
Role |
Type |
Shares |
Price |
Value |
| 2026-03-10 |
Woods Eugene A. |
Director |
RSU Award |
155 |
- |
- |
| 2026-03-10 |
Pinto Daniel E |
Director |
RSU Award |
129 |
- |
- |
| 2026-03-10 |
Hewson Marillyn A |
Director |
RSU Award |
206 |
- |
- |
| 2025-03-04 |
Hewson Marillyn A |
Director |
RSU Award |
75 |
- |
- |
| 2026-02-27 |
Decker Robert J |
VP Corporate Controller |
Option Exercise (Sell) |
4,075 |
$115.67 |
$471.36K |
| 2026-02-20 |
Schmid Timothy |
EVP, Ww Chair, Medtech |
Informative Sell |
1,322 |
$245.66 |
$324.76K |
| 2026-02-15 |
Mulholland Kristen |
EVP, Chief HR Officer |
Option Exercise (Sell) |
419 |
- |
- |
| 2026-02-13 |
Mulholland Kristen |
EVP, Chief HR Officer |
Option Exercise (Sell) |
410 |
- |
- |
| 2026-02-18 |
Schmid Timothy |
EVP, Ww Chair, Medtech |
Option Exercise (Sell) |
13,625 |
$115.67 |
$1.58M |
| 2026-02-15 |
Schmid Timothy |
EVP, Ww Chair, Medtech |
Option Exercise (Sell) |
1,028 |
- |
- |
| 2026-02-13 |
Schmid Timothy |
EVP, Ww Chair, Medtech |
Option Exercise (Sell) |
4,378 |
- |
- |
| 2026-02-15 |
Forminard Elizabeth |
EVP, Chief Legal Officer |
Option Exercise (Sell) |
961 |
- |
- |
| 2026-02-13 |
Forminard Elizabeth |
EVP, Chief Legal Officer |
Option Exercise (Sell) |
651 |
- |
- |
| 2026-02-17 |
Broadhurst Vanessa |
EVP, Global Corp Affairs |
Informative Sell |
6,197 |
$243.39 |
$1.51M |
| 2026-02-15 |
Broadhurst Vanessa |
EVP, Global Corp Affairs |
Option Exercise (Sell) |
492 |
- |
- |
| 2026-02-13 |
Broadhurst Vanessa |
EVP, Global Corp Affairs |
Option Exercise (Sell) |
408 |
- |
- |
| 2026-02-17 |
Swanson James D. |
EVP, CIO |
Option Exercise (Sell) |
20,521 |
$164.62 |
$3.38M |
| 2026-02-15 |
Swanson James D. |
EVP, CIO |
Option Exercise (Sell) |
492 |
- |
- |
| 2026-02-13 |
Swanson James D. |
EVP, CIO |
Option Exercise (Sell) |
19,368 |
$165.89 |
$3.21M |
| 2026-02-15 |
Decker Robert J |
VP Corporate Controller |
Option Exercise (Sell) |
339 |
- |
- |
| 2026-02-13 |
Decker Robert J |
VP Corporate Controller |
Option Exercise (Sell) |
312 |
- |
- |
| 2026-02-15 |
Wengel Kathryn E |
EVP, Chief To and Risk Officer |
Option Exercise (Sell) |
606 |
- |
- |
| 2026-02-13 |
Wengel Kathryn E |
EVP, Chief To and Risk Officer |
Option Exercise (Sell) |
13,706 |
- |
- |
| 2026-02-15 |
Taubert Jennifer L |
EVP, Wwc. Innovative Medicine |
Option Exercise (Sell) |
1,594 |
- |
- |
| 2026-02-13 |
Taubert Jennifer L |
EVP, Wwc. Innovative Medicine |
Option Exercise (Sell) |
1,302 |
- |
- |
